R&G Pharma: Abnormal fluctuations in stock trading

R&G Pharma announced that the closing price deviation of the company's stock exceeded 30% cumulatively over three consecutive trading days on October 29, 2025, October 30, 2025, and October 31, 2025. There are no corrections or supplements needed for the information previously disclosed by the company, and there have been no significant changes in the company's operating conditions or internal and external operating environment recently. The company, its controlling shareholders, and actual controllers do not have any significant matters related to the company that should be disclosed but have not been disclosed